Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014*
Authors:
- Guillermo Dominguez-CheritGDGuillermo Dominguez-Cherit
- Silvio A. Ñamendys-SilvaSÑSilvio A. Ñamendys-Silva
- 1 October 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 44 (10) , 1861-1870
Abstract
Objectives: The 2009–2010 influenza A (H1N1pdm09) pandemic caused substantial morbidity and mortality among young patients; however, mortality estimates have been confounded by regional differences in eligibility criteria and inclusion of selected populations. In 2013–2014, H1N1pdm09 became North America’s dominant seasonal influenza strain. Our objective was to compare the baseline characteristics, resources, and treatments with outcomes among critically ill patients with influenza A (H1N1pdm09) in Mexican and Canadian hospitals in 2014 using consistent eligibility criteria. Design: Observational study and a survey of available healthcare setting resources. Setting: Twenty-one hospitals, 13 in Mexico and eight in Canada. Patients: Critically ill patients with confirmed H1N1pdm09 during 2013–2014 influenza season. Interventions: None. Measurements and Main Results: The main outcome measures were 90-day mortality and independent predictors of mortality. Among 165 adult patients with H1N1pdm09-related critical illness between September 2013 and March 2014, mean age was 48.3 years, 64% were males, and nearly all influenza was community acquired. Patients were severely hypoxic (median Pao 2-to-Fio 2 ratio, 83 mm Hg), 97% received mechanical ventilation, with mean positive end-expiratory pressure of 14 cm H2O at the onset of critical illness and 26.7% received rescue oxygenation therapy with prone ventilation, extracorporeal life support, high-frequency oscillatory ventilation, or inhaled nitric oxide. At 90 days, mortality was 34.6% (13.9% in Canada vs 50.5% in Mexico, p < 0.0001). Independent predictors of mortality included lower presenting Pao 2-to-Fio 2 ratio (odds ratio, 0.89 per 10-point increase [95% CI, 0.80–0.99]), age (odds ratio, 1.49 per 10 yr increment [95% CI, 1.10–2.02]), and requiring critical care in Mexico (odds ratio, 7.76 [95% CI, 2.02–27.35]). ICUs in Canada generally had more beds, ventilators, healthcare personnel, and rescue oxygenation therapies. Conclusions: Influenza A (H1N1pdm09)-related critical illness still predominantly affects relatively young to middle-aged patients and is associated with severe hypoxemic respiratory failure. The local critical care system and available resources may be influential determinants of patient outcome.Keywords
This publication has 16 references indexed in Scilit:
- Critically Ill Patients With Influenza A(H1N1)pdm09 Virus Infection in 2014JAMA, 2014
- Critical care and the global burden of critical illness in adultsThe Lancet, 2010
- Critically Ill Patients With 2009 Influenza A(H1N1) in MexicoJAMA, 2009
- Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress SyndromeJAMA, 2009
- Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaJAMA, 2009
- The 2009 pandemic H1N1 influenza and indigenous populations of the Americas and the PacificEurosurveillance, 2009
- Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoNew England Journal of Medicine, 2009
- Clinical review: Critical care in the global context – disparities in burden of illness, access, and economicsCritical Care, 2008
- Updating the Accounts: Global Mortality of the 1918-1920 "Spanish" Influenza PandemicBulletin of the History of Medicine, 2002
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failureIntensive Care Medicine, 1996